NCT06029647

Brief Summary

This research study will determine the effects of mango consumption on blood pressure, body weight, dietary nutrient/pattern changes, total cholesterol, LDL-cholesterol, VLDL-cholesterol, triglycerides, and HDL-cholesterol in individuals with moderately elevated blood pressure and/or LDL-cholesterol.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P50-P75 for not_applicable healthy

Timeline
Completed

Started Sep 2023

Typical duration for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 26, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 8, 2023

Completed
10 days until next milestone

Study Start

First participant enrolled

September 18, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 12, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 12, 2024

Completed
Last Updated

February 13, 2025

Status Verified

February 1, 2024

Enrollment Period

12 months

First QC Date

August 26, 2023

Last Update Submit

February 11, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Blood pressure (mm Hg)

    Systolic and diastolic blood pressure will be measured.

    16 weeks for mango consumption and 16 weeks for vanilla wafer consumption

Secondary Outcomes (3)

  • Body weight (kg) and height (cm)

    16 weeks for mango consumption and 16 weeks for vanilla wafer consumption

  • Blood lipids (mg/dL)

    16 weeks for mango consumption and 16 weeks for vanilla wafer consumption

  • Dietary analysis (six 24-hour dietary recalls per person in each treatment arm)

    16 weeks for mango consumption and 16 weeks for vanilla wafer consumption

Study Arms (2)

Mango

EXPERIMENTAL

The participants will consume one cup of fresh mango (100 kcal) per day for sixteen weeks.

Other: Mango

Wafer

PLACEBO COMPARATOR

The participants will consume vanilla wafers (100 kcal) per day for sixteen weeks.

Other: vanilla wafers

Interventions

MangoOTHER

The participants will consume the treatment for 16 weeks, followed by a 4-week washout period.

Mango

vanilla wafers

Wafer

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Apparently healthy students (18 to 40 years)
  • Attend California State Polytechnic University, Pomona
  • Moderately elevated blood pressure (systolic greater than 120 mm Hg or diastolic greater than 80 mm Hg) and/or LDL-cholesterol (greater than 100 mg/dL)

You may not qualify if:

  • Smokers
  • Pregnancy
  • Any medical issues
  • Allergies or dislike of mangos
  • Allergies to wheat, milk, eggs, and/or soy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

California State Polytechnic University, Pomona

Pomona, California, 91768, United States

Location

Related Publications (9)

  • GBD 2017 Diet Collaborators. Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019 May 11;393(10184):1958-1972. doi: 10.1016/S0140-6736(19)30041-8. Epub 2019 Apr 4.

    PMID: 30954305BACKGROUND
  • Lee-Kwan SH, Moore LV, Blanck HM, Harris DM, Galuska D. Disparities in State-Specific Adult Fruit and Vegetable Consumption - United States, 2015. MMWR Morb Mortal Wkly Rep. 2017 Nov 17;66(45):1241-1247. doi: 10.15585/mmwr.mm6645a1.

    PMID: 29145355BACKGROUND
  • Gorinstein S, Zemser M, Haruenkit R, Chuthakorn R, Grauer F, Martin-Belloso O, Trakhtenberg S. Comparative content of total polyphenols and dietary fiber in tropical fruits and persimmon. J Nutr Biochem. 1999 Jun;10(6):367-71. doi: 10.1016/s0955-2863(99)00017-0.

    PMID: 15539312BACKGROUND
  • Papanikolaou Y, Fulgoni VL 3rd. Mango Consumption Is Associated with Improved Nutrient Intakes, Diet Quality, and Weight-Related Health Outcomes. Nutrients. 2021 Dec 24;14(1):59. doi: 10.3390/nu14010059.

    PMID: 35010933BACKGROUND
  • Arshad F, Umbreen H, Aslam I, Hameed A, Aftab K, Al-Qahtani WH, Aslam N, Noreen R. Therapeutic Role of Mango Peels in Management of Dyslipidemia and Oxidative Stress in Obese Females. Biomed Res Int. 2021 Oct 23;2021:3094571. doi: 10.1155/2021/3094571. eCollection 2021.

    PMID: 34725636BACKGROUND
  • Evans SF, Beebe M, Mahmood M, Janthachotikun S, Eldoumi H, Peterson S, Payton M, Perkins-Veazie P, Smith BJ, Lucas EA. Mango Supplementation Has No Effects on Inflammatory Mediators in Obese Adults. Nutr Metab Insights. 2017 Sep 25;10:1178638817731770. doi: 10.1177/1178638817731770. eCollection 2017.

    PMID: 28983188BACKGROUND
  • O'Hara C, Ojo B, Emerson SR, Simenson AJ, Peterson S, Perkins-Veazie P, Payton ME, Hermann J, Smith BJ, Lucas EA. Acute Freeze-Dried Mango Consumption With a High-Fat Meal has Minimal Effects on Postprandial Metabolism, Inflammation and Antioxidant Enzymes. Nutr Metab Insights. 2019 Aug 19;12:1178638819869946. doi: 10.1177/1178638819869946. eCollection 2019.

    PMID: 31452602BACKGROUND
  • Rosas M Jr, Pinneo S, O'Mealy C, Tsang M, Liu C, Kern M, Hooshmand S, Hong MY. Effects of fresh mango consumption on cardiometabolic risk factors in overweight and obese adults. Nutr Metab Cardiovasc Dis. 2022 Feb;32(2):494-503. doi: 10.1016/j.numecd.2021.11.001. Epub 2021 Nov 12.

    PMID: 34953634BACKGROUND
  • Ross SM. African mango (IGOB131): a proprietary seed extract of Irvingia gabonensis is found to be effective in reducing body weight and improving metabolic parameters in overweight humans. Holist Nurs Pract. 2011 Jul-Aug;25(4):215-7. doi: 10.1097/HNP.0b013e318222735a. No abstract available.

    PMID: 21697664BACKGROUND

MeSH Terms

Interventions

Mangifera indica extract

Study Officials

  • Erik Froyen, PhD

    Cal Poly Pomona

    PRINCIPAL INVESTIGATOR
  • Bonny Burns-Whitmore, DrPH, RD

    Cal Poly Pomona

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: The study will follow a randomized, controlled, crossover design with two 16-week dietary interventions separated by 4-week washout periods.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 26, 2023

First Posted

September 8, 2023

Study Start

September 18, 2023

Primary Completion

September 12, 2024

Study Completion

September 12, 2024

Last Updated

February 13, 2025

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

We do not plan to share the data with other researchers.

Locations